Sun Pharmaceutical Industries Limited
SUNPHARMAVerifiedThe largest pharmaceutical company in India and 4th largest global specialty generic firm, with strong research capabilities in dermatology and ophthalmology.
Stock Snapshot & Key Numbers — Sun Pharmaceutical Industries Limited
Verified Daily CloseOfficial closing price, 1-year price range, valuation multiples, and market value from exchange records.
Sun Pharmaceutical Industries Limited (SUNPHARMA) is a Indian equity security listed on the NSE/BSE with ISIN INE044A01036. As of the last recorded market session on Close on 16 Oct 2026, the stock closed at ₹1758.80, recording a -5.20 (-0.29%) decline from its previous close of ₹1764.00. Over the trailing 52-week trading cycle, SUNPHARMA has traded between a 52-week low of ₹1589.30 and a 52-week high of ₹2001.10, establishing its annual trading channel. In historical performance, Sun Pharmaceutical Industries Limited has gained 6.02% over the past 1 year. Period returns across standard measurement intervals include: 1-week: -0.07%, 1-month: -5.11%, 6-month: +3.88%, 1-year: +6.02%, 3-year: +54.92%, 5-year: +110.41%. Daily reported trading volume reached 15,22,459 equity shares. On key valuation multiples as of 11 Oct 2026, the company trades at a trailing price-to-earnings (P/E) multiple of 34.9x and a price-to-book (P/B) ratio of 5.0x, with a trailing dividend yield of 0.91%. Its market capitalization stands at ₹4.22 Lakh Cr. The company is categorized under the Healthcare & Pharma sector and Specialty Pharmaceuticals & Generics industry within the Indian equities universe.
Price Chart
Trading Multiples & Ranges
Price boundaries and liquidity distribution.
Past Price Win/Loss Odds (1-Week, 1-Month, 3-Month)
How often this stock rose, stayed flat, or fell over past 21-day holding periods (based on historical data, not a future prediction).
How Outside Factors Affect This Stock (Market, Crude Oil & Currency)
How closely this stock moved with the broader market index, crude oil, and the exchange rate over the past year.
| Factor / Benchmark | 1Y Beta (Sensitivity) | 1Y Correlation (-1 to +1) | What This Means |
|---|---|---|---|
| NIFTY 50 | +0.46 | +0.32 | Trailing 1Y historical sensitivity: a 1% move in NIFTY 50 coincided with a +0.46% co-movement (correlation: 0.32). Descriptive historical relationship, not predictive. |
| USD / INR | -0.06 | -0.03 | Trailing 1Y historical sensitivity: a 1% move in USD / INR coincided with a -0.06% co-movement (correlation: -0.03). Descriptive historical relationship, not predictive. |
| Brent Crude Oil | -0.01 | -0.03 | Trailing 1Y historical sensitivity: a 1% move in Brent Crude Oil coincided with a -0.01% co-movement (correlation: -0.03). Descriptive historical relationship, not predictive. |
| US 10Y Treasury Yield | +0.06 | +0.04 | Trailing 1Y historical sensitivity: a 1% move in US 10Y Treasury Yield coincided with a +0.06% co-movement (correlation: 0.04). Descriptive historical relationship, not predictive. |
How to read Beta & Correlation ( Beta > 1 = wider swings than market; < 1 = calmer )▾
Sensitivities measure historical 1-year regression beta and correlation across paired daily trading sessions over the past 252 trading days. Past relationships can shift over time and do not guarantee future co-movement.
Trailing Returns Breakdown
Calendar-aligned historical percentage performance across standard market windows.
| Period | Start Price | Current Price | Return (%) |
|---|---|---|---|
| 1 Week | ₹1,760.00 | ₹1,758.80 | -0.07% |
| 15 Days | ₹1,801.00 | ₹1,758.80 | -2.34% |
| 1 Month | ₹1,853.50 | ₹1,758.80 | -5.11% |
| 3 Months | ₹1,950.10 | ₹1,758.80 | -9.81% |
| 6 Months | ₹1,693.10 | ₹1,758.80 | +3.88% |
| 1 Year | ₹1,659.00 | ₹1,758.80 | +6.02% |
| 3 Years | ₹1,135.30 | ₹1,758.80 | +54.92% |
| 5 Years | ₹835.90 | ₹1,758.80 | +110.41% |
Price Swings & Biggest Historical Drops
How much this stock typically fluctuates and its largest peak-to-bottom drops over 1 and 5 years.
Calendar-Year Historical Performance
Annual performance breakdown comparing first and last closing sessions of each calendar year.
| Calendar Year | Start Close | End Close | Annual Return | Trajectory Bar |
|---|---|---|---|---|
| CY 2026 | ₹1,721.10 | ₹1,758.80 | +2.2% | |
| CY 2025 | ₹1,889.95 | ₹1,719.70 | -9.0% | |
| CY 2024 | ₹1,260.25 | ₹1,886.35 | +49.7% | |
| CY 2023 | ₹997.00 | ₹1,259.45 | +26.3% | |
| CY 2022 | ₹848.95 | ₹1,001.40 | +18.0% | |
| CY 2021 | ₹835.90 | ₹845.70 | +1.2% |
Historical Investment Simulator
Factual simulation of past returns in Sun Pharmaceutical Industries Limited (SUNPHARMA) using real recorded closing prices.
Corporate Actions & Distributions
Historical record of dividend payouts and share split adjustments for SUNPHARMA.
Dividend Distributions (2)
| Ex-Date | Dividend Amount |
|---|---|
| 7 Jul 2026 | ₹5.00 per share |
| 5 Feb 2026 | ₹11.00 per share |
Stock Splits & Multipliers (0)
No stock split adjustments recorded.
Recent News & Official Exchange Announcements
Official exchange filings, order wins, and company updates. Click any announcement to see how it affects the business on the right.
Sun Pharmaceutical Industries Q1 Results FY27: Uniresearch Predictions, Analyst Views and Key Watchpoints - Univest
Sun Pharmaceutical Industries Q1 Results FY27: Uniresearch Predictions, Analyst Views and Key Watchpoints Univest
Sun Pharmaceutical Industries Ltd spurts 2.14% - Business Standard
Sun Pharmaceutical Industries Ltd spurts 2.14% Business Standard
Is It Smart To Buy Sun Pharmaceutical Industries Limited (NSE:SUNPHARMA) Before It Goes Ex-Dividend? - Simply Wall Street
Is It Smart To Buy Sun Pharmaceutical Industries Limited (NSE:SUNPHARMA) Before It Goes Ex-Dividend? Simply Wall Street
Sun Pharma Q1 net profit rises 27 percent to Rs 2,894 crore, misses estimates; revenue also below poll - Moneycontrol.com
Sun Pharma Q1 net profit rises 27 percent to Rs 2,894 crore, misses estimates; revenue also below poll Moneycontrol.com
NSE Becomes 10th Most Valued Listed Company In India As Market Cap Crosses Rs 4.5 Lakh Crore - NDTV Profit
NSE Becomes 10th Most Valued Listed Company In India As Market Cap Crosses Rs 4.5 Lakh Crore NDTV Profit
Why This Matters for the Business
Plain-English breakdown of how the selected announcement connects to revenue, costs, and business drivers.
Quarterly financial statements disclosed under statutory SEBI LODR Regulation 33.
- •Quarterly financial results disclosed under SEBI LODR Regulation 33
Volume throughput absorbs fixed manufacturing plant overheads, supporting operating EBITDA margins and cash generation across healthcare & pharma units.
Continuous commercial tenders and capital expenditures lock in forward order book-to-bill expansion.
At-a-Glance Health & Momentum Check
Company filings and balance-sheet numbers show steady day-to-day operations with stable margins and working capital.
Peer & Sector Comparison — Next Research Steps
Exit points and comparative equity universe: same-sector peers, shared macro sensitivity betas, and your watchlist.
Common Questions About Sun Pharmaceutical Industries Limited (SUNPHARMA)
Key facts on SUNPHARMA share price, historical returns, valuation ratios, and past SIP performance.
What is the current share price and 52-week range of Sun Pharmaceutical Industries Limited (SUNPHARMA)?
As of 16 Oct 2026, the official closing share price of Sun Pharmaceutical Industries Limited (SUNPHARMA) on NSE/BSE is ₹1,758.80 (-0.29% vs the previous close). Over the past 52 weeks, SUNPHARMA has traded between a low of ₹1,589.30 and a high of ₹2,001.10, with a reported market capitalization of ₹4.22 Lakh Cr.
What are the historical returns of Sun Pharmaceutical Industries Limited (SUNPHARMA)?
Based on split-adjusted closing prices through 16 Oct 2026, Sun Pharmaceutical Industries Limited (SUNPHARMA) recorded the following trailing price returns: 1 Week: -0.07% (from ₹1,760.00 to ₹1,758.80); 15 Days: -2.34% (from ₹1,801.00 to ₹1,758.80); 1 Month: -5.11% (from ₹1,853.50 to ₹1,758.80); 3 Months: -9.81% (from ₹1,950.10 to ₹1,758.80); 6 Months: +3.88% (from ₹1,693.10 to ₹1,758.80); 1 Year: +6.02% (from ₹1,659.00 to ₹1,758.80); 3 Years: +54.92% (from ₹1,135.30 to ₹1,758.80); 5 Years: +110.41% (from ₹835.90 to ₹1,758.80). Past performance reflects historical exchange records and does not predict future returns.
What is the P/E ratio, P/B ratio, and dividend yield of Sun Pharmaceutical Industries Limited (SUNPHARMA)?
Sun Pharmaceutical Industries Limited (SUNPHARMA) currently trades at a trailing Price-to-Earnings (P/E) ratio of 34.9x, a Price-to-Book (P/B) ratio of 5.0x, and a trailing 12-month dividend yield of 0.91%. It operates in the Healthcare & Pharma sector (Specialty Pharmaceuticals & Generics).
How much would a past lump-sum or monthly SIP investment in SUNPHARMA have grown?
Based on historical closing prices for Sun Pharmaceutical Industries Limited (SUNPHARMA): A one-time lump-sum investment of ₹1,00,000.00 held for 5 years would be worth ₹2,10,407.94 (+110.4% total return, 16.1% CAGR), while a monthly SIP of ₹10,000.00 over 5 years (total invested: ₹6,10,000.00) would be worth ₹8,55,699.37 (+40.3% absolute return). You can test custom amounts and holding periods in the interactive calculator above.
Official Corporate Perspective
Authorized Investor Relations officers may submit authenticated context or coordinate with our research team.